Cassava Sciences Stock (NASDAQ:SAVA), Quotes and News Summary

Q: What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.

Open	$21.010
Close	$19.640
Volume / Avg.	1.312M / 723.593K
Day Range	19.470 - 21.195
52 Wk Range	12.320 - 32.100
Market Cap	$849.347M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	29.31%
Days to Cover	25.29

Recent News

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Avi Kapoor

Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report

The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following a critical inspection report by the Food and Drug Administration.

Benzinga Neuro

Boeing, Oracle, Meta Platforms, Cassava Sciences, Tesla: Why These 5 Stocks Are On Investors' Radars Today

On Monday, the U.S. stock market presented a mixed performance. The Dow Jones index managed to turn higher, trading up by 0.12% to 38,769.66.

Benzinga Neuro

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cassava Sciences Inc

Sector

Health Care

Industry

Pharmaceuticals

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific ap...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cassava Sciences (SAVA) stock?

You can purchase shares of Cassava Sciences (NASDAQ: SAVA) through any online brokerage.

View our list of the best stock brokerages.

Who are Cassava Sciences's (SAVA) competitors?

Other companies in Cassava Sciences’s space includes: GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA) and WAVE Life Sciences (NASDAQ:WVE).

What is the target price for Cassava Sciences (SAVA) stock?

The latest price target for Cassava Sciences (NASDAQ: SAVA) was reported by HC Wainwright & Co. on Tuesday, March 5, 2024. The analyst firm set a price target for 124.00 expecting SAVA to rise to within 12 months (a possible 531.36% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Cassava Sciences (SAVA)?

The stock price for Cassava Sciences (NASDAQ: SAVA) is $19.64 last updated Today at April 19, 2024 at 4:38 PM EDT.

Does Cassava Sciences (SAVA) pay a dividend?

A quarterly cash dividend of $0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.

When is Cassava Sciences (NASDAQ:SAVA) reporting earnings?

Cassava Sciences’s Q1 earnings are confirmed for Friday, May 3, 2024.

Is Cassava Sciences (SAVA) going to split?

There is no upcoming split for Cassava Sciences.

What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-